Programmed cell death, or apoptosis, is inhibited by the antiapoptotic oncogene, Bcl-2, and is mediated by a cascade of aspartate-speci®c cysteine proteases, or caspases, related to interleukin 1-b converting enzyme. Depending on cell type, apoptosis can be induced by treatment with thapsigargin (TG); a selective inhibitor of the endoplasmic reticulum-associated calcium-ATPase. The role of caspases in mediating TG-induced apoptosis was investigated in the Bcl-2-negative human breast cancer cell line, MDA-MB-468. Apoptosis developed in MDA-MB-468 cells over a period of 24 ± 72 h following treatment with 100 nM TG, and was prevented by Bcl-2 overexpression. TG-induced apoptosis was associated with activation of caspase-3 and was inhibited by stable expression of the baculovirus p35 protein, an inhibitor of caspase activity. Also, TG-induced apoptosis was inhibited by treating cells with Z-VAD-fmk, a cellpermeable¯uoromethylketone inhibitor of caspases. These ®ndings indicate that TG-induced apoptosis of MDA-MB-468 breast cancer cells is subject to inhibition by Bcl-2 and is mediated by caspase activity. This model system should be useful for further investigation directed toward understanding the role of calcium in signaling apoptosis, and its relationship to Bcl-2 and the caspase proteolytic cascade.
Introduction
Programmed cell death (PCD), or apoptosis, is important for proper development and homeostasis of tissues; thus, insight into PCD mechanisms will contribute to improved understanding and treatment of diseases in which the normal balance between cell proliferation and cell death is disrupted (Thompson, 1995) . For example, the PCD process mediates both the physiologic involution of normal breast epithelium following lactation and the regression of breast cancer following hormonal manipulation or chemotherapy administration (McCloskey et al., 1996) .
Studies in the primitive nematode, C. elegans, have contributed considerably to our understanding of fundamental PCD mechanisms by proving that apoptosis involves a systematic, stepwise process of cellular destruction regulated by genes encoding either death inhibitors or eectors (Steller, 1995) . For example, the C. elegans gene ced-9 encodes an inhibitor of cell death, whereas the ced-3 and ced-4 genes encode death eectors. Mammalian cells express genes homologous to ced-9 and ced-3, indicating that the apoptotic pathway is highly conserved. The mammalian homolog of ced-9 is bcl-2, a potent inhibitor of apoptosis that prevents PCD triggered by diverse death signals (Cory, 1995) . The mammalian homolog of ced-3 is the cysteine protease, interleukin 1-b converting enzyme (ICE) (Yuan et al., 1993) . ICE, along with a number of ICE-like proteases, or caspases, compose a family of cysteine proteases that cleave proteins at aspartic acid residues (Henkart, 1996) . Recent ®ndings suggest that a caspase proteolytic cascade mediates cell death by cleaving selected target proteins (Martin and Green, 1995; Fraser and Evan, 1996) . Bcl-2 appears to inhibit apoptosis by preventing caspase activation Chinnaiyan et al., 1996; Jacobson et al., 1996; Shimizu et al., 1996) . ICE-like proteases have been implicated as mediators of apoptosis in response to a variety of death signals, including trophic factor deprivation, protein kinase inhibition by staurosporine, and cytotoxic lymphocyte killing (Milligan et al., 1995; Jacobson et al., 1996; Martin et al., 1996) . Thus, activation of a caspase cascade may be a ®nal common pathway where diverse cell death signals converge.
We have been investigating the mechanism of cell death signaling following inhibition of calcium ion uptake into the endoplasmic reticulum (ER) by the sesqueterpene lactone tumor promoter thapsigargin (TG). In lymphoma cells, TG treatment induces apoptotic cell death, which can be prevented by Bcl-2 overexpression (Lam et al., 1993 (Lam et al., , 1994 . In the present report, we show that TG also induces apoptosis in the human breast cancer cell line, MDA-MB-468, and that TG-induced apoptosis involves caspase-3 activation and is prevented by expressing the baculovirus antiapoptotic protein p35, an inhibitor of caspases (Bump et al., 1995) . Also, we show that TG-induced apoptosis can be inhibited by treating cells with a cell-permeable, irreversible, tripeptide inhibitor of caspases, Z-Val-AlaAsp-¯uoromethylketone (Z-VAD-fmk) (Jacobson et al., 1996) . These ®ndings indicate that TG-induced apoptosis is mediated through a highly conserved PCD process regulated by Bcl-2 and mediated by caspases.
Results
When treated with 100 nM TG, MDA-MB-468 cells underwent apoptotic cell death. The distinction between viable cells and apoptotic cells was based on nuclear chromatin pattern, assessed by¯uorescence microscopy of cells stained with acridine orange (Figure 1 ). The nuclear chromatin of viable cells was dispersed, whereas that of apoptotic cells was condensed into densely¯uorescent apoptotic bodies. To test the eect of Bcl-2 on TG-induced apoptosis, MDA-MB-468 cells were stably transfected with pSFFV-neo-Bcl-2 or pSFFV-neo, producing 468-Bcl-2 and 468-neo cells, respectively. Bcl-2 was present at very low levels in 468-neo cells, but was readily detected by Western blotting in 468-Bcl-2 cells (Figure 2a) . Following exposure to 100 nM TG, 468-neo cells underwent apoptosis, which evolved over a period of 24 ± 72 h (Figure 2b) . Thus, the kinetics of apoptosis induction were much slower than reported previously in lymphoma cells, where a peak in the percentage of apoptotic cells was detected within 12 h of adding 100 nM TG (McCormick et al., 1997) . TGinduced apoptosis was markedly repressed in 468-Bcl-2 cells, representative of multiple Bcl-2-expressing clones, indicating that TG-induced apoptosis is mediated through a Bcl-2-regulated pathway (Figure 2b ).
To determine if TG-induced apoptosis is associated with caspase activation, the level of pro-caspase-3 (CPP32, Yama, or apopain) was assessed in MDA-MB-468 cells by Western blotting using a monoclonal antibody to human pro-caspase-3. During activation, pro-caspase-3 undergoes cleavage to two subunits that form the active heterotetramer (Henkart, 1996) . The level of pro-caspase-3 declined within 48 h of TG addition, indicating conversion of pro-caspase-3 to an active form (Figure 3 ). Two methods were employed to determine whether or not ICE-like protease activation is a necessary step in TG-induced apoptosis. In the ®rst, MDA-MB-468 cells were stably transfected with the pSFFV-neo expression vector into which the cDNA encoding p35, a baculovirus inhibitor of ICElike proteases, had been cloned. Cells stably transfected with this vector are referred to as 468-p35 cells, while cells stably transfected with empty vector alone are referred to as 468-neo cells. p35 mRNA was detected by Northern hybridization in two 468-p35 subclones (1 and 4), but not in 468-neo cells (Figure 4 ). On light microscopy, healthy 468-neo cells have a somewhat elongated appearance and are adherent to plastic tissue culture wells, whereas apoptotic cells have a small rounded appearance and are non-adherent ( Figure 5 ). Following treatment of 468-neo cells with TG, there was a marked increase in the proportion of apoptotic cells. Untreated 468-p35 cells have an appearance similar to that of 468-neo cells, except that fewer spontaneously apoptotic cells were observed in culture. In addition, fewer apoptotic cells were detected in cultures of 468-p35 cells following TG treatment compared to TG-treated cultures of 468-neo cells. To corroborate these ®ndings, the percentage of apoptotic cells following TG treatment was quantitated bȳ uorescence microscopy ( Figure 6a ). The data confirm the inhibition of TG-induced apoptosis by p35.
In a second approach, cells were treated with TG in the presence or absence of the peptide fluoromethylketone inhibitor Z-VAD-fmk. The tripeptide sequence in Z-VAD-fmk corresponds to the P 1 to P 3 residues of the pro-IL-1b cleavage site (Tyr   4   ValAlaAsp   1 Gly), where ICE cleaves between the Asp and Gly residue (Yuan et al., 1993) . Deletion of the Tyr residue broadens the inhibitory spectrum to include not only ICE, but other proteases closely related to ICE. An eective treatment regimen was empirically derived in which cells were treated with 200 mM doses of Z-VAD-fmk added 1 h prior to TG, and every 12 h thereafter over a period of 48 h. Z-VAD-fmk had a marked inhibitory eect on Control Thapsigargin Protein was isolated from MDA-MB-468 cells that had been stably transfected with pSFFV-neo (468-neo) or pSFFV-neo-Bcl-2 (468-Bcl-2). Protein (50 mg) was resolved by SDS ± PAGE and analysed by Western blotting using a Bcl-2 monoclonal primary antibody. (b) The percentage of 468-neo and 468-Bcl-2 cells with an apoptotic nuclear morphology at various times after adding 100 nM TG was measured by¯uorescence microscopy as described in Figure 1 . Symbols represent the mean+s.e. of four experiments TG-induced apoptosis (Figure 6b ), whereas Z-FA-fmk, a cathepsin inhibitor, actually induced cell death (data not shown).
Discussion
In experiments reported here, we found that TG treatment induces apoptosis of MDA-MB-468 cells, an estrogen receptor negative human breast cancer cell line that has been employed by others to investigate PCD in breast cancer (Armstrong et al., 1992 (Armstrong et al., , 1994 .
Our ®ndings add to the number of recognized cell types in which TG treatment induces apoptosis, including normal thymocytes (Jiang et al., 1994) , lymphoma cells (Lam et al., 1993 (Lam et al., , 1994 and prostate carcinoma cells . However, not all cell types readily undergo apoptosis following TG treatment. For example, smooth muscle cells, ®broblasts and epithelial cells have been reported to undergo growth arrest, without loss of viability, following TG treatment (Ghosh et al., 1989; Li et al., 1993) . In the case of smooth muscle cells, survival in the presence of TG is mediated through induction of TG-insensitive calcium pumps that restore calcium homeostasis within the ER lumen (Waldron et al., 1995) ; whereas in the case of ®broblasts and epithelial cells, maintenance of cell viability following TG treatment is dependent upon the induction of the grp78 and grp94 genes encoding the resident ER calcium-binding proteins, GRP78 and GRP94 respectively (Li et al., 1993) . Moreover, the rate of cell death induction following TG treatment also varies among dierent types of cells. For example, in lymphoma cells, TG treatment induces rapid onset of apoptosis within less than 12 h; whereas, as shown in the present study, induction of apoptosis in breast cancer cells evolves more slowly following TG treatment. In part, the kinetics of cell death induction in TG-treated cells may depend upon the magnitude of grp78/grp94 induction, a concept based on the observation that grp78/grp94 induction is detected in TG-treated breast cancer cells, but not in TG-treated lymphoma cells (McCormick et al., 1997) .
The mechanism of apoptosis induction by TG is not fully understood, but appears to be directly related to inhibition of ER calcium-ATPase activity, which produces sustained elevation of cytosolic calcium and sustained depletion of the ER calcium pool (Thastrup et al., 1990) . Apoptosis induction may be signaled in response to cytosolic calcium elevation, consistent with evidence that factors interfering with cytosolic calcium elevation inhibit TG-induced apoptosis (Jiang et al., 1994; Furuya et al., 1994) . Also, it is possible that ER calcium pool depletion may trigger apoptosis, a concept that is both supported by experimental evidence (Reynolds and Eastman, 1996) and consistent with the fact that the ER calcium pool is essential for a number of vital cellular functions, including protein processing (Lodish et al., 1992) , signal transduction (Schonthal et al., 1991; Little and Lee, 1995) , and cell division (Short et al., 1993) . Because Bcl-2 is associated with the ER/perinuclear membrane, in addition to the outer mitochondrial membrane, we suggested the possibility that Bcl-2 might inhibit apoptosis by regulating calcium¯uxes across intracellular membranes (Lam et al., 1994) , a concept that is intriguing in view of recent evidence that Bcl-XL, a Bcl-2 homolog, has a structure consistent with that of an ion channel (Muchmore et al., 1996) . The present report extends our understanding of TG-induced apoptosis by providing evidence of involvement of ICE-like proteases. One type of evidence is the inhibition of TG-induced apoptosis by baculovirus p35, an inhibitor of a number of ICEfamily proteases (Bump et al., 1995) . Expression of p35 has been used by others to document the involvement of ICE-like proteases in mediating PCD in insect cells (Cartier et al., 1994) , C. elegans (Sugimoto et al., 1994) , Drosophila (Hay et al., 1994) , and mammalian cells (Rabizadeh et al., 1993; Beidler et al., 1995) . Therefore, inhibition of TG-induced cell death in MDA-MB-468 cells expressing p35 suggests that ICE-like protease activity is essential for apoptosis induction by TG. Although p35 mRNA expression in transfected cells was detected by RT ± PCR, p35 protein was not detected (data not shown). This is consistent with earlier data indicating that low level p35 expression is sucient to inhibit apoptosis . Moreover, inhibition of ICE-like proteases by p35 involves p35 cleavage, reducing the level of intact p35 protein available for detection by Western blotting (Bump et al., 1995; Xue and Horvitz, 1995) .
A second type of evidence for involvement of ICElike proteases in TG-induced apoptosis is the inhibition observed in cells exposed to Z-VAD-fmk. The use of this reagent to con®rm the role of ICE-like proteases in mediating apoptosis in response to several dierent signals has been reported previously (Zhu et al., 1995; Jacobson et al., 1996) . It is important to note that the concentration of Z-VAD-fmk employed in our experiments, although in the micromolar range, did not repress cell growth or decrease cell viability, whereas a control peptide¯uoromethylketone, Z-FAfmk, was toxic to cells.
In summary, the ®ndings of the present study indicate that TG induces apoptosis of MDA-MB-468 cells, mediated through a highly conserved, Bcl-2-regulated process that involves ICE-like proteases. This model system should be useful for further investigation directed toward understanding the role of calcium in apoptosis signaling, and its relationship to Bcl-2 and the ICE-like proteolytic cascade.
Materials and methods

Materials
TG was purchased from LC Laboratories and serum from Hyclone. Antibiotics were from Gibco BRL. Benzyloxycarbonyl-Val-Ala-Asp (O-methyl)-¯uoromethylketone (ZVal-Ala-Asp (O-Me)-CH 2 F; Z-VAD-fmk) and benzyloxycarbonyl-Phe-Ala-¯uoromethylketone (Z-Phe-Ala-fmk; Z-FA-fmk) were from Enzyme Systems Products, Inc. All other chemicals, unless noted otherwise, were obtained from Sigma. Monoclonal antibody to human pro-caspase-3 was from Transduction Laboratories.
Cell Culture and Treatment Conditions
MDA-MB-468 human breast cancer cells (from M Lippman, Georgetown University) were cultured in Improved Minimal Figure 6 Eect of baculovirus p35 and Z-VAD-fmk on TGinduced apoptosis. (a) MDA-MB-468 transfectants, 468-neo and 468-p35 (clones 1 and 4), were treated with 100 nM TG. The percentage of cells with an apoptotic nuclear morphology was determined by¯uorescence microscopy at the indicated times after adding TG. Symbols represent the mean+s.e. of multiple cell counts in two separate experiments. (b) MDA-MB-468 cells were treated with 100 nM TG in the presence or absence of Z-VAD-fmk. TG (100 nM) was added to cells at time 0. Z-VADfmk (200 mM) was added to one set of cells 1 h before adding TG and at 12, 24, and 36 h thereafter. The percentage of cells with an apoptotic nuclear morphology was determined by¯uorescence microscopy at the indicated time points after adding TG. Symbols represent the mean of multiple determinations in a single experiment that was repeated once with the same result Essential Medium (Bio¯uids) supplemented with 10% (v/v) heat-inactivated fetal bovine serum, 50 units/ml penicillin and 50 mg/ml streptomycin at 378C in a 7% CO 2 atmosphere.
A 1 mg/ml stock of TG was made in DMSO and stored in aliquots at 7208C. A working stock was prepared by diluting TG in fresh culture medium to a ®nal concentration of 1 mM. TG was then added to the cell cultures to achieve the desired ®nal concentrations as noted in the text. Untreated cultures received the same volumes of DMSO without TG. Z-FA-fmk and Z-VAD-fmk were dissolved in DMSO to give a ®nal concentration of 50 mM and added to 1 ml culture wells at a ®nal concentration of 100 or 200 mM respectively 1 h before adding TG and every 12 h thereafter for a total of four additions.
Cell viability and apoptosis assays
Cells were counted on a hemocytometer after suspension in trypan blue dye. Viability was de®ned by the ability of cells to exclude trypan blue dye. Apoptotic cells were detected bȳ uorescence microscopy, using a previously published method (McCormick et al., 1997) . Brie¯y, ®ve million cells were gently pelleted and resuspended in 0.2 ml tissue culture medium and both ethidium bromide and acridine orange were added from 100 mg/ml stock solutions to achieve 4 mg/ ml ®nal concentrations of each. Cells were examined under a glass coverslip with u.v. illumination using a Nikon Optiphot microscope and cells were scored as apoptotic according to nuclear morphological changes, including chromatin condensation and apoptotic body formation.
Western blotting
Levels of Bcl-2 in cell lysates were measured by Western blotting as described previously using the 15131A monoclonal antibody (PharMingen) (Lam et al., 1994) . To assess the level of caspase-3 at various time points after treatment with 100 nM TG, cells were washed twice with ice cold phosphate buered saline and then lysed for 40 min in RIPA buer (50 mM Tris-HCl, pH 7.6, 150 mM NaCl, 1% triton-X-100, 0.1% SDS, 1 mM PMSF, 1 mg/ml leupeptin). The lysates were centrifuged in a microfuge at 13 200 r.p.m. for 10 min at 48C, the supernatants collected and the protein concentrations determined by the Bio-Rad Protein Assay (Bio-Rad Laboratories, Hercules, California). Thirty mg of each protein lysate was resolved by electrophoresis on a 14% SDS-polyacrylamide gel under reducing conditions, and transferred to PVDF membrane (Millepore Co., Bedford, Massachusetts). The membranes were incubated in 5% non-fat dry milk in T-TBS (18 mM Tris-HCl, pH 7.6, 122 mM NaCl, 0.1% Tween-20) at room temperature for 2 h and then incubated with monoclonal antibody to human caspase-3.
(Transduction Laboratories, Lexington, Kentucky) at 1 : 1000 dilution at 48C for 18 h, followed by goat antirabbit IgG conjugated with horseradish peroxidase (GIBCO BRL, Gaithersburg, Maryland). The immune complexes were detected with the ECL Western blotting detection reagents (Amersham Corporation, Arlington Heights, Illinois) according to the manufacturer's protocol, followed by exposure to X-ray ®lm (Sigma, St Louis, Missouri).
Vector construction and transfection
MDA-MB-468 cells were transfected by the calcium phosphate method (GIBCO/BRL Calcium Phosphate Transfection System) with the pSFFV-Bcl-2 expression vector, described previously (Cuende et al., 1993) . Stable transfectants were isolated by resistance to G418. The full length cDNA encoding baculovirus p35 (P Friesen) was cloned in the sense direction into the pSFFV-neo vector (G Nunez), producing pSFFV-p35. MDA-MB-468 cells were transfected with either pSFFV-neo or pSFFV-p35 by the calcium phosphate method and stably transfected, G418-resistant, clones were isolated.
Northern blotting
Total cellular RNA was prepared using TRIZOL Reagent (GIBCO BRL). Thirty mg RNA per sample was separated by electrophoresis in a 1.2% agarose gel and blotted onto a nitrocellulose membrane. The blot was prehybridized at 658C for 30 min and hybridized with a-32 P-dCTP-labeled (Stratagene Prime-It II Kit) plasmid pPRM-35K-ORF containing the full length cDNA for baculovirus p35 .
